Labiotech.eu

News and Trends 12 Feb 2018

Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide

Swiss pharma Roivant has given French biotech Poxel €28M upfront to get involved with the development and commercialization of imeglimin, a new treatment for metabolic disorders like type 2 diabetes. Poxel uses its expertise in metabolism to develop drugs for the treatment of disorders like type 2 diabetes. Its candidate imeglimin has caught the eye of […]

February 12, 2018 - 3 minutesmins - By Alex Dale

News and Trends 12 Feb 2018

First Functioning Kidney Tissue Generated from Embryonic Stem Cells

Researchers at the University of Manchester have used embryonic stem cells to produce kidney tissue that can filter the blood to produce urine, which opens the door to personalized kidney transplants. Scientists at the University of Manchester have generated human kidney tissue from embryonic stem cells for the first time. The research, published in the journal Stem […]

February 12, 2018 - 3 minutesmins - By Alex Dale

Interview 12 Feb 2018

MorphoSys’ CEO Tells Us What’s Next for Europe’s Antibody Expert

After 25 years, MorphoSys finally got over the line in 2017 with the FDA approval of its first antibody. CEO Simon Moroney tells us how the company hopes to build on its recent success. It may have started out as a tech provider, but MorphoSys now stands as one of the leading German biotechs, specializing […]

February 12, 2018 - 8 minutesmins - By Alex Dale

News and Trends 10 Feb 2018

Superbugs: Fighting Antibiotic Resistance at the Science Museum

An exhibition at the Science Museum London features some of the deadliest superbugs on Earth and the stories of the people fighting against the threat of antibiotic resistance. It is estimated that, by 2050, 10 million people will die every year due to infections with antibiotic-resistant bacteria. Meaning that the numbers will be higher than […]

February 10, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Startup Scout 9 Feb 2018

This Polish Biotech Uses AI to Help Others Speed Up Precision Medicine Development

Following on from BioNext’s software last week, we’re in Kraków to visit Ardigen. This biotech develops technology to help us decipher the huge amount of data generated by research. Mission: Ardigen came to our attention when it finished 2nd place in the prestigious NCI-CPTAC DREAM-Proteogenomics Challenge – a competition with more than 500 competitors. Universities and research institutes […]

February 9, 2018 - 1 minutemin - By Alex Dale

News and Trends 8 Feb 2018

GSK’s Company Starts Phase III Trials with Two-Drug HIV Treatment

ViiV Healthcare has just started a clinical trial to test if its two-drug regimen for HIV can work as well as current three-drug HIV treatment. Most antiretroviral treatments used to keep HIV at bay employ a combination of three different drugs, exposing patients to the long-term toxicity of three different compounds at once. London-based ViiV […]

February 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

janssen biotech theravance bowel inflammation

News and Trends 8 Feb 2018

Janssen Biotech Offers up to $1Bn to Irish Biotech for a Bowel Inflammation Drug

Janssen Biotech and Theravance Biopharma will develop together a drug to treat bowel inflammation diseases like ulcerative colitis and Crohn’s disease. Janssen Biotech has set its eyes on a drug candidate being developed by the Irish Theravance Biopharma. Both have entered an agreement to co-develop and commercialize the drug. In exchange, Theravance is getting $100M (€82M) […]

February 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Feb 2018

Scottish CAR-T Biotech Adds Another Stellar Partner to Its Roster

TC Biopharm has signed a new pharma partner, the Japan-based NIPRO Corporation, who will give the biotech a leg up in the CAR-T game. Hot on the heels of the two huge CAR-T acquisitions of Juno and Kite, Japanese pharma NIPRO Corporation is planting a foot in the game by partnering with Scotland-based TC Biopharm […]

February 7, 2018 - 1 minutemin - By Evelyn Warner

News and Trends 7 Feb 2018

January Has Been the Best Month Ever for Biotech in Spain

Biotech in Spain has kicked off 2018 setting a record for the number of acquisitions and fundraisings and their total value combined. Early in January, the Japanese big pharma Takeda announced its intention to acquire TiGenix for €520M. The cell therapy biotech was born in 2011 as a merger of Belgian TiGenix and Spanish Cellerix, […]

February 7, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 7 Feb 2018

Hookipa CEO “Sleeps Quite Well at Night” with €50M Cash Pile and Cancer Vaccine Progress

Did you miss us in Vienna? Here’s the first of our two interviews from the Refresh meetup last month: Jörn Aldag, CEO of Hookipa, talked to us about the importance of a sound financial strategy and where cancer vaccines are on the hype curve. Jörn Aldag has had quite a career. His first position as […]

February 7, 2018 - 4 minutesmins - By Evelyn Warner

News and Trends 6 Feb 2018

Spring Cleaning: AstraZeneca Ditches Underperforming Asthma and Cancer Candidates

AstraZeneca has given up on the development of its PD-1 checkpoint inhibitor drug, which was the headline act when its subsidiary MedImmune acquired Amplimmune in 2013. There was no sentiment as pharma giant AstraZeneca cut a number of drugs from its pipeline after they did not perform as expected during clinical trials. The biggest name to get […]

February 6, 2018 - 3 minutesmins - By Alex Dale

More News! 6 Feb 2018

Biotech Barometer: How is biotech doing on the European markets?

How did biotech finish last year on Euronext? The exchange has released its report for H2 of 2017 for the 49 biotechs listed on the markets, including giants Galapagos and Ablynx and CAR-T notables Cellectis and Celyad among others. The bottom line of the biotech barometer? It was a good semester! Stock Performance & Market […]

February 6, 2018 - 3 minutesmins - By Evelyn Warner

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide

First Functioning Kidney Tissue Generated from Embryonic Stem Cells

MorphoSys’ CEO Tells Us What’s Next for Europe’s Antibody Expert

Superbugs: Fighting Antibiotic Resistance at the Science Museum

This Polish Biotech Uses AI to Help Others Speed Up Precision Medicine Development

GSK’s Company Starts Phase III Trials with Two-Drug HIV Treatment

Janssen Biotech Offers up to $1Bn to Irish Biotech for a Bowel Inflammation Drug

Scottish CAR-T Biotech Adds Another Stellar Partner to Its Roster

January Has Been the Best Month Ever for Biotech in Spain

Hookipa CEO “Sleeps Quite Well at Night” with €50M Cash Pile and Cancer Vaccine Progress

Spring Cleaning: AstraZeneca Ditches Underperforming Asthma and Cancer Candidates

Biotech Barometer: How is biotech doing on the European markets?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!